Bronstein, Gewirtz & Grossman LLC Files Class Action Against Insulet Corporation

GlobeNewswire··Read original
2▲0 ▼1Impact / 5
Summary · why it matters

Bronstein, Gewirtz & Grossman LLC has filed a class action lawsuit against Insulet Corporation and certain officers, alleging violations of federal securities laws. The suit covers investors who purchased or acquired Insulet securities between May 21, 2025 and May 26, 2026. The complaint claims that defendants made false and misleading statements about the company's business, operations, and compliance policies, specifically that manufacturing controls were defective, creating a foreseeable risk of safety violations or injury. Investors have until August 31, 2026 to seek lead plaintiff appointment. The law firm represents investors on a contingency fee basis.

Impact on assets 1

Biotech & Genomic Medicine▼ · 1 stocks
Insulet Corporation
PODD
▼ NegativeRegulationrelevance

Class action lawsuit alleging securities law violations and defective manufacturing controls.